Gernandt & Danielsson advises Netel’s existing lenders in connection with the merger between Netel and Infrea
Gernandt & Danielsson advises Netel’s existing lenders on new financing arrangements relating to the proposed merger between Netel and Infrea.
Gernandt & Danielsson advises Vaaka Partners Buyout Fund IV Ky on the acquisition of HifabGruppen AB
Gernandt & Danielsson advises Vaaka Partners Buyout Fund IV Ky in connection with its acquisition of HifabGruppen AB from Hultström Group AB (publ). The transaction, which is subject to approval at an extraordinary general meeting, is expected to be completed during the third quarter of 2026.
Gernandt & Danielsson advises in Citira’s issue of secured bonds
Gernandt & Danielsson advises in Citira’s issue of secured bonds in an initial amount of EUR 60 million. ABG Sundal Collier, Pareto Securities and Skandinaviska Enskilda Banken (the “Joint Bookrunners”) have acted as joint bookrunners in relation to the bond issue.
Gernandt & Danielsson advises SBP Kredit in its issuance of secured loan notes and redemption under its outstanding secured green participating debentures
Gernandt & Danielsson advises SBP Kredit AB (publ) (“SBP Kredit”) in connection with its issue of new secured loan notes in an amount of SEK 750,000,000 under a total framework of SEK 3,000,000,000, as well as in connection with SBP Kredit’s concurrent redemption under its outstanding secured green participating debentures. SBP Kredit will apply for …
Health Canada releases guidance on biosimilar biologic drug submissions
In May 2026, Health Canada published its Guidance on Information and Submission Requirements for Biosimilar Biologic Drugs. This guidance sets out the regulatory framework under which biosimilar sponsors may seek a Notice of Compliance (NOC) for a biosimilar biologic drug in Canada.
Canada unveils national AI strategy: Key commitments, regulatory gaps, and what’s missing
On June 4, 2026, the Government of Canada released AI for All: Canada’s National Artificial Intelligence Strategy, a 50-page, multi-billion-dollar plan positioning Canada as a global AI leader across six strategic pillars (protecting Canada/democracy, empowering Canadians, powering prosperity, sovereign AI infrastructure, scaling Canadian AI, and international partnerships) and five priority sectors (health/life sciences, energy/natural resources, transportation, agriculture, …
Equal treatment wage rules for federally regulated employers
At a glance Effective 20 October 2026, new “Equal Treatment” wage rules under the Canada Labour Code (the Code) will require equal pay for employees regardless of employment status (full-time, part-time, permanent, or temporary).
Federally regulated employers face a new era for non-compete clauses under Bill C-31
Bill C-31’s proposed amendments to the Canada Labour Code signal a shift in the regulation of workplace restrictive covenants in Canada. If enacted, the legislation would significantly limit the use of non-compete clauses for federally regulated employers and continue a broader national trend favouring employee mobility and labour market competition.
Executive Order No. 407/2026 issues new regulations for Argentina’s employment laws
On June 1, 2026, Executive Order No. 407/2026 (Order) was published in Argentina’s Official Gazette, implementing regulations for various provisions of the Employment Contract Law No. 20,744 (LCT), as amended by the Labor Modernization Act No. 27,802, in addition to regulations governing collective bargaining (Law No. 14,250), trade union organizations (Law No. 23,551), temporary staffing agencies …
Puerto Rico Supreme Court validates non-compete clauses in independent contractor agreements
For the first time, the Puerto Rico Supreme Court has upheld the validity of non-compete clauses in contracts with independent contractors, specifically in the healthcare sector, and, in doing so, it has established the framework for their enforcement. In this alert, we outline the Court’s opinion in MCG Therapy Group LLC v. Maestre Rivera and set out key takeaways …